AquaBounty Technologies (NASDAQ:AQB) Announces Quarterly Earnings Results

AquaBounty Technologies (NASDAQ:AQB) posted its quarterly earnings data on Tuesday. The company reported ($0.88) EPS for the quarter, hitting analysts’ consensus estimates of ($0.88), RTT News reports. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. The company had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. During the same quarter in the previous year, the firm earned ($1.60) earnings per share.

AquaBounty Technologies Trading Down 4.3 %

AQB opened at $1.10 on Thursday. AquaBounty Technologies has a 1-year low of $0.81 and a 1-year high of $4.03. The stock has a market capitalization of $4.25 million, a PE ratio of -0.06 and a beta of 1.15. The company has a current ratio of 1.96, a quick ratio of 1.96 and a debt-to-equity ratio of 0.05. The firm has a 50-day moving average price of $1.13 and a two-hundred day moving average price of $1.47.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.